4//SEC Filing
Rios Israel 4
Accession 0000880771-11-000019
CIK 0000880771other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 1:30 PM ET
Size
5.9 KB
Accession
0000880771-11-000019
Insider Transaction Report
Form 4
Rios Israel
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2011-05-27+14,971→ 14,971 total→ Common Stock (14,971 underlying)
Footnotes (4)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
- [F3]25% of the restricted stock units will vest on April 5, 2012, April 5, 2013, April 5, 2014, and April 5, 2015, unless the trading window is closed for the Reporting Person on each date, then the vesting date will be deferred until the next date that the trading window is open.
- [F4]25% of the restricted stock units will vest on April 5, 2012, April 5, 2013, April 5, 2014 and April 5, 2015, unless the trading window is closed for the Reporting Person on that date, then the vesting date will be deferred until the next date that the trading window is open.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeother
Related Parties
1- filerCIK 0001464104
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 1:30 PM ET
- Size
- 5.9 KB